Amino triazole

Aminotriazole is presented as a weed killer whose residues on marketed cranberries triggered a public controversy in 1959. Its importance in the book lies not only in the laboratory evidence linking it to thyroid tumors in rats, but also in the dispute over whether that evidence should be accepted as a warning about a chemical entering the food supply. The episode brings together pesticide toxicity, uncertainty about human risk, and the pressures that can determine whether scientific findings reach the public.

The cranberry controversy

In 1959, some cranberry growers misused aminotriazole, leaving residues on berries that were marketed to consumers. The Food and Drug Administration seized contaminated cranberries, and the resulting controversy turned on a central question: whether aminotriazole was in fact cancer-producing. The book emphasizes that this was not merely an argument about a possible hazard in the abstract. The chemical had been used in a way that led to residues on food for sale, making the assessment of its carcinogenic properties a matter of public concern.

The claim that aminotriazole caused cancer was widely challenged, including by many medical men. Against that skepticism, the book points to scientific facts released by the Food and Drug Administration, which it presents as clear evidence of the chemical’s carcinogenic nature in laboratory rats. The clash between the challenge and the experimental findings makes the controversy an example of how a public risk can be contested even when animal evidence is available.

Evidence from laboratory rats

The reported experiment exposed rats to aminotriazole in their drinking water at a concentration of 100 parts per million, described as one teaspoonful of the chemical in ten thousand teaspoonfuls of water. At the sixty-eighth week, the animals began to develop thyroid tumors. After two years, tumors were present in more than half of the rats examined. They were diagnosed as several kinds of growth, both benign and malignant.

Tumors also appeared at lower feeding levels. The book stresses that no level of feeding that produced no effect had been found. That finding gives the experiment particular force in the account: the evidence did not establish a harmless threshold within the tested range. It did not, however, determine the level at which aminotriazole might cause cancer in people. The discussion therefore keeps distinct the demonstrated result in rats and the unresolved question of human risk.

Exposure and uncertainty

The cranberry episode sits within a broader account of how pesticide exposure may occur through food and how chemicals can persist in the body. The book describes DDT residues on foodstuffs as a route of intake: even the smallest intake can begin storage, with the chemical accumulating in fatty tissues because it is fat-soluble. Since such stored pesticides are only slowly excreted, repeated exposure can contribute to chronic poisoning and degenerative changes in the liver and other organs. This account of accumulation supplies a wider context for concern about residues, although it does not claim that aminotriazole behaves identically to DDT.

The book also warns that people are not exposed to only one chemical at a time. Interactions among insecticides and other chemicals can complicate the assessment of risk. In one example, Food and Drug Administration scientists found that simultaneous administration of malathion and certain other organic phosphates could cause poisoning far more severe than a simple addition of their individual effects would predict. This evidence is not an aminotriazole experiment; it supports the book’s broader point that chemical exposure in real conditions may be mixed, making isolated assessments an incomplete guide.

Public knowledge and the meaning of the case

The dispute over aminotriazole forms part of the book’s larger concern with the circulation of information about pesticide dangers. When Rachel Carson tried to interest magazines in an article about pesticides, publishers turned her down because they feared losing advertising. A canned baby-food manufacturer argued that such an article would create unwarranted fear among mothers using his product. The episode shows how commercial interests could bear on whether pesticide risks were discussed in public, providing a relevant backdrop to a controversy in which the cancer-producing evidence itself was widely challenged.

Aminotriazole’s place in the book is thus defined by both the specific experimental record and the limits of what that record could establish. Rat studies showed thyroid tumors, including at lower feeding levels, while the human carcinogenic level remained unknown. The cranberry residues made that distinction consequential: uncertainty about the precise risk to people did not erase the evidence in animals or the fact that the chemical had reached marketed food. The case turns the gap between experimental knowledge and human certainty into a question of public judgment rather than a reason to treat the evidence as settled in neither direction.